Highlights
- 1The Journal of biological chemistry · 2024
Publications
8 publications
Funding
5 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- KPBMGF INV-055894Gene inactivation and modulation of Mtb targets to build combinationsBill & Melinda Gates Foundation · 2023–2026
- KPR01AI161013-01Harnessing B Cells For TB Vaccine Development To Improve Therapy Of TB And TB-HIV CoinfectionNational Institute of Allergy and Infectious Diseases · 2021–2026 · via Center for Discovery and Innovation
Completed grants (3)
- KPBMGF 210849-01Conditional M. tuberculosis knockdown mutants for TB drug discovery (INV-004761)Bill & Melinda Gates Foundation · 2020–2023
- KPINV-004764Partial gene inactivation and pharmacological modulation of Mtb targets (INV-004764)Bill & Melinda Gates Foundation · 2020–2023
- KPBMGF INV-009731Vulnerability of M. Tuberculosis to Partial Gene InactivationBill & Melinda Gates Foundation · 2017–2021